先天性心脏病体肺动脉分流术的当代结局:单中心回顾性研究
该单中心回顾性研究纳入2008至2023年565例使用膨体聚四氟乙烯人工血管行体肺动脉分流术(SPS)的先天性心脏病患者,按3个手术年代分层分析。目标手术达成率84.6%,目标手术前死亡12.4%(早期死亡4.6%);6个月目标手术前生存率从年代1的83%提升至年代3的94%(P=.007)。
要点
- 当代SPS术后目标手术前生存率较早期年代显著改善。
- 功能单心室、低体重和胸骨正中切开与早期死亡风险升高相关。
- 较高剂量阿司匹林方案与目标手术前总体死亡风险降低相关。
核心结论
- 当代SPS术后结局较早期年代改善,可能反映围手术期管理的进步。
研究设计与样本
- 单中心回顾性研究,纳入2008至2023年565例使用膨体聚四氟乙烯人工血管行SPS的先天性心脏病患者。
- 按手术年代分为3组:年代1为2008-2013年,年代2为2014-2018年,年代3为2019-2023年。
主要发现
- SPS时中位年龄25天,中位体重3.44 kg。
- 478例(84.6%)达成目标手术:双心室修复272例、双向Glenn分流178例、一个半心室修复24例、转为其他姑息类型4例。
- 目标手术前死亡69例(12.4%),其中早期死亡24例(4.6%)。
- 目标手术前6个月生存率从年代1的83%提升至年代3的94%(P=.007)。
- 失访15例,3例SPS未进一步处理仍保留原位。
关键数值与推荐
- 早期死亡与功能单心室(OR 3.13;P=.02)、SPS时较低体重(OR 4.17;P=.002)、胸骨正中切开入路(OR 21.75;P=.003)相关。
- 目标手术前总体死亡与功能单心室(HR 3.19;P<.001)、肺动脉闭锁(HR 1.79;P=.04)、SPS前心脏手术(HR 2.40;P=.04)、SPS时合并心血管操作(HR 2.08;P=.004)、较大移植血管直径与体重比(HR 1.13;P=.05)相关。
- 较高剂量阿司匹林方案具有保护作用(HR 0.54;P=.02)。
临床怎么用
- 对功能单心室、低体重及需胸骨正中切开的高危SPS患者应加强围手术期管理。
- SPS时选择合适直径的移植血管并考虑较高剂量阿司匹林方案可能改善目标手术前生存。
局限性
- 单中心回顾性设计可能限制结果的普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic-to-pulmonary shunt (SPS) remains an essential palliative procedure for congenital heart disease. We assessed contemporary outcomes after SPS. METHODS: We retrospectively reviewed 565 patients who underwent SPS with expanded polytetrafluoroethylene grafts between 2008 and 2023. Patients were stratified into 3 surgical eras to evaluate temporal trends: era 1, 2008-2013; era 2, 2014-2018; and era 3, 2019-2023. RESULTS: Median age and body weight at SPS were 25 days and 3.44 kg, respectively. Target operations (TOs) were achieved in 478 patients (84.6%): biventricular repair (n = 272), bidirectional Glenn shunt (n = 178), one-and-a-half ventricle repair (n = 24), and transition to other types of palliation (n = 4). Loss to follow-up occurred in 15 patients; SPS remained in situ without further treatment in 3 patients. Mortality before TO occurred in 69 patients (12.4%), including 24 early deaths (4.6%). Pre-TO survival at 6 months improved significantly across eras, from 83% in era 1 to 94% in era 3 (P = .007). On logistic regression, early mortality was associated with a functionally single ventricle (odds ratio [OR], 3.13; P = .02), lower body weight at SPS (OR, 4.17; P = .002), and a sternotomy approach (OR, 21.75; P = .003). On Cox regression, pre-TO overall mortality was associated with a functionally single ventricle (hazard ratio [HR], 3.19; P < .001), pulmonary atresia (HR, 1.79; P = .04), pre-SPS cardiac surgery (HR, 2.40; P = .04), concomitant cardiovascular procedures at SPS (HR, 2.08; P = .004), and larger graft diameter to body weight ratio (HR, 1.13; P = .05). A higher dose aspirin protocol was protective (HR, 0.54; P = .02). CONCLUSIONS: Outcomes after SPS have improved in the contemporary era, likely reflecting advances in perioperative management.
引用
- Song Y, Kim DH, Choi ES, et al. Contemporary Outcomes of Systemic-to-Pulmonary Shunt in Patients With Congenital Heart Disease: A Single-Center Retrospective Study. Ann Thorac Surg. 2026. PMID: 42190820. doi:10.1016/j.athoracsur.2026.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。